News & Updates

Pretoria, 13 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) recently released a media statement on the falsified Ozempic products currently being sold on the market and online, specifically unauthorised Ozempic/semaglutide-containing products. SAHPRA has registered one product which contains semaglutide called Ozempic. There...

The establishment of the African Medicines Agency (AMA) will significantly contribute to the improvement of healthcare delivery across the continent and better overall health of African citizens. Africa continues to be a growing continent in many aspects. It is expected that the population of young Africans...

Pretoria, 06 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is currently conducting a Stakeholder Satisfaction Survey through an independent market research agency, MarkData (Pty) Ltd. SAHPRA has commissioned MarkData to conduct these surveys to better understand its effectiveness in implementing its regulatory...

SAHPRA offices will be closed for the festive season from 12:00 on Friday, 22 December 2023 and will re-open on Tuesday, 02 January 2024. Submissions to SAHPRA New Medicine, Variation, License, Renewal Applications Applications/submissions must reach SAHPRA by 14 December 2023 at 13:00 to allow for the administrative...